Joline Dalton

Parkinson Research Foundation — United States

Neuroscience · Life Sciences

20h-index2.6kcitations50works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(17), Muscle Physiology and Disorders(13), Mitochondrial Function and Pathology(6), Parkinson's Disease Mechanisms and Treatments(5), Genomics and Rare Diseases(5)

Publications50 total

The Impact of Forced-Rate Exercise and/or Photobiomodulation Compared to Usual Care on Metabolic Syndrome Severity in People with Parkinson’s Disease: a randomised controlled crossover-study
Journal of science and medicine in sport·2024Open Access
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
JAMA Network Open·2022· 12 citedOpen Access
562: UNDERUTILIZATION OF A MEDICAL POLICY COVERING UNIVERSAL MICROSATELLITE INSTABILITY, IMMUNOHISTOCHEMISTRY, AND GENETIC TESTING IN ALL PATIENTS DIAGNOSED WITH COLORECTAL CANCER - A REAL WORLD DATA ANALYSIS
Gastroenterology·2022
Abstract 10555: Genetic Testing Underutilization in Patients with Cardiomyopathy: A Real-World Data Analysis
Circulation·2021· 4 cited
Clinical impact of medical policy supporting universal germline testing for patients with colorectal cancer.
Journal of Clinical Oncology·2021· 2 cited
Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing
Clinical Chemistry·2021· 5 citedOpen Access
The genetic landscape of axonal neuropathies in the middle-aged and elderly
Neurology·2020· 30 citedOpen Access
Cobblestone Malformation in <i>LAMA2</i> Congenital Muscular Dystrophy (MDC1A)
Journal of Neuropathology & Experimental Neurology·2020· 20 citedOpen Access
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
Acta Neuropathologica·2019· 46 citedOpen Access
Correction: TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants
Genetics in Medicine·2018· 2 citedOpen Access
TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants
Genetics in Medicine·2018· 69 citedOpen Access
DUCHENNE MUSCULAR DYSTROPHY – CLINICAL
Neuromuscular Disorders·2018
De novo, deleterious sequence variants that alter the transcriptional activity of the homeoprotein PBX1 are associated with intellectual disability and pleiotropic developmental defects
Human Molecular Genetics·2017· 54 citedOpen Access
A case of childhood onset of treatable sensory neuronopathy caused by mutations in riboflavin transporter RFVT2 presenting as pure sensory ataxia with excellent response to riboflavin – a five year follow up
Neuromuscular Disorders·2017· 2 cited
Congenital fiber type disproportion myopathy and novel compound heterozygous mutations in the RYR1 gene. Next generation sequencing – A first line diagnostic tool for congenital myopathy
Neuromuscular Disorders·2016
Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures
The American Journal of Human Genetics·2016· 116 citedOpen Access
Muscle ultrasound in Duchenne muscular dystrophy: Useful tool to monitor progression of early disease
Neuromuscular Disorders·2015
MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain
Cell Reports·2015· 151 citedOpen Access
The Myopathies
2014
Overview of Adult Muscular Dystrophies
2014
page 1 of 3Next →

Frequent Co-authors

John Day(26), Laura P.W. Ranum(17), Peter Karachunski(13), Kevin M. Flanigan(5), Jacinda B. Sampson(5), Anne M. Connolly(5), Julaine Florence(4), Elizabeth C. Malkus(4), Jeanine Schierbecker(4), Catherine Siener(4), Charlie Wulf(4), Pallavi Anand(4), Linda Lowes(4), L. Viollet-Callendret(4), Craig M. McDonald(4), Erica Goude(4), Alina Nicorici(4), Basil T. Darras(4), Chad Moretz(4), Kathryn E. Hatchell(4)